Search research articles
Contact Us
Filters
Showing results (21-30 of 53) with videos related to
Page
of 6
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
February 16, 2013
Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients
Sajo Kaduthanam, Stephan Gade, Michael Meister, et al.
Virchows Archiv : an International Journal of Pathology
|
September 15, 2014
Preanalytical variables and performance of diagnostic RNA-based gene expression analysis in breast cancer
Christopher Poremba, Jennifer Uhlendorff, Berit M Pfitzner, et al.
Pharmacoeconomics
|
November 19, 2014
Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients
Patricia R Blank, Martin Filipits, Peter Dubsky, et al.
Journal for Immunotherapy of Cancer
|
June 21, 2022
Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with <i>BRAF</i> V600-mutant melanoma: exploratory biomarker analyses from a randomized phase 3 trial (COMBI-i)
Hussein A Tawbi, Caroline Robert, Jan C Brase, et al.
BMC Cancer
|
December 7, 2011
TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
Jan C Brase, Marc Johannes, Heiko Mannsperger, et al.
British Journal of Cancer
|
October 20, 2012
Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer
S Darb-Esfahani, R Kronenwett, G von Minckwitz, et al.
Breast Cancer Research : BCR
|
February 9, 2013
HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer
Carsten Denkert, Jens Huober, Sibylle Loibl, et al.
Breast Cancer Research : BCR
|
April 15, 2014
Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial
Miguel Martin, Jan C Brase, Lourdes Calvo, et al.
The Lancet. Oncology
|
February 15, 2021
Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study
Mahrukh M Syeda, Jennifer M Wiggins, Broderick C Corless, et al.
BMC Cancer
|
October 9, 2012
Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test
Ralf Kronenwett, Kerstin Bohmann, Judith Prinzler, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 53) with videos related to
Sort By:
Page
of 6
Lung Cancer (Amsterdam, Netherlands)
|
February 16, 2013
Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients
Sajo Kaduthanam, Stephan Gade, Michael Meister, et al.
Virchows Archiv : an International Journal of Pathology
|
September 15, 2014
Preanalytical variables and performance of diagnostic RNA-based gene expression analysis in breast cancer
Christopher Poremba, Jennifer Uhlendorff, Berit M Pfitzner, et al.
Pharmacoeconomics
|
November 19, 2014
Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients
Patricia R Blank, Martin Filipits, Peter Dubsky, et al.
Journal for Immunotherapy of Cancer
|
June 21, 2022
Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with <i>BRAF</i> V600-mutant melanoma: exploratory biomarker analyses from a randomized phase 3 trial (COMBI-i)
Hussein A Tawbi, Caroline Robert, Jan C Brase, et al.
BMC Cancer
|
December 7, 2011
TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
Jan C Brase, Marc Johannes, Heiko Mannsperger, et al.
British Journal of Cancer
|
October 20, 2012
Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer
S Darb-Esfahani, R Kronenwett, G von Minckwitz, et al.
Breast Cancer Research : BCR
|
February 9, 2013
HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer
Carsten Denkert, Jens Huober, Sibylle Loibl, et al.
Breast Cancer Research : BCR
|
April 15, 2014
Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial
Miguel Martin, Jan C Brase, Lourdes Calvo, et al.
The Lancet. Oncology
|
February 15, 2021
Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study
Mahrukh M Syeda, Jennifer M Wiggins, Broderick C Corless, et al.
BMC Cancer
|
October 9, 2012
Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test
Ralf Kronenwett, Kerstin Bohmann, Judith Prinzler, et al.
Page
of 6